Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH
11 Dec 2023 //
BUSINESSWIRE
Cimeio Therapeutics Announces Poster Presentations at ASH 2023
03 Nov 2023 //
BUSINESSWIRE
Cimeio Therapeutics Announces Publication of Seminal Epitope Editing Work
29 Sep 2023 //
BUSINESSWIRE
Prime Medicine and Cimeio Therapeutics Announce Research Collaboration
22 Jun 2023 //
GLOBENEWSWIRE
Cimeio Therapeutics Presents Additional Proof-of-Concept Data for SCIP Platform
16 May 2023 //
BUSINESSWIRE
Cimeio Therapeutics Announces Acceptance of ASH Abstracts Detailing Pipeline
03 Nov 2022 //
BUSINESSWIRE